Medpace 2022 annual meeting: director Keating gets more withheld than 'for' votes; say-on-pay passes 72%

Medpace Holdings, Inc.

Directors August Troendle and Ashley Keating elected to Class III board; Keating received 12,863,441 for vs. 17,722,711 withheld.
Ratification of Deloitte & Touche as FY2022 auditor passed with 30,576,845 votes for (96.5% of votes cast).
Advisory say-on-pay proposal approved with 22,093,994 votes for (72.3% excluding broker non-votes) and 8,458,621 against.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.